LD-2 disclosure · 2nd Quarter - Report
ALLERGAN USA, INC.
via ALLERGAN USA, INC.
Client
- Name
- ALLERGAN USA, INC.
- Location
- District of Columbia · United States of America
Registrant
- Firm
- ALLERGAN USA, INC.
- Description
- Pharmaceutical development and manufacturing
- Location
- WASHINGTON, District of Columbia, United States of America
Lobbying activities
8 issuesCopyright/Patent/Trademark
Intellectual property protections for novel therapies to treat crucial medical needs. Patent reform proposals.
LobbyistsBRENT J FISK · ROBERT W. LIVELY
TargetedSENATE · HOUSE OF REPRESENTATIVES · Patent & Trademark Office (PTO) · Food & Drug Administration (FDA) · Centers For Medicare and Medicaid Services (CMS)
Taxation/Internal Revenue Code
Tax policy including changes to corporate tax structure. Tax codes that ensure investment in research & development of novel treatments for patients.
LobbyistsBRENT J FISK · ROBERT W. LIVELY
TargetedSENATE · HOUSE OF REPRESENTATIVES · Patent & Trademark Office (PTO) · Food & Drug Administration (FDA) · Centers For Medicare and Medicaid Services (CMS)
Health Issues
Access to appropriate mental health care treatments across the U.S. Creating access to Long Acting Reversible Contraceptives for patients in areas impacted by the Zika virus. Supporting investment in safe, quality, accessible, and affordable biopharma products. Ensuring level and appropriate penalties for those harming patients by illegally diverting and counterfeiting pharmaceutical products.
BRENT J FISK · ROBERT W. LIVELY